Trade Mustang Bio, Inc. - MBIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.38 |
| Open | 0.39 |
| 1-Year Change | -88.25% |
| Day's Range | 0.38 - 0.39 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 18, 2024 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.38 |
| Apr 15, 2024 | 0.38 | -0.10 | -20.83% | 0.48 | 0.48 | 0.38 |
| Apr 12, 2024 | 0.49 | -0.03 | -5.77% | 0.52 | 0.52 | 0.49 |
| Apr 11, 2024 | 0.51 | 0.02 | 4.08% | 0.49 | 0.52 | 0.49 |
| Apr 10, 2024 | 0.49 | -0.15 | -23.44% | 0.64 | 0.65 | 0.49 |
| Apr 9, 2024 | 0.65 | -0.04 | -5.80% | 0.69 | 0.69 | 0.62 |
| Apr 8, 2024 | 0.65 | -0.08 | -10.96% | 0.73 | 0.78 | 0.64 |
| Apr 5, 2024 | 0.73 | -0.04 | -5.19% | 0.77 | 0.79 | 0.73 |
| Apr 4, 2024 | 0.75 | -0.08 | -9.64% | 0.83 | 0.84 | 0.72 |
| Apr 3, 2024 | 0.82 | -0.12 | -12.77% | 0.94 | 0.97 | 0.79 |
| Apr 2, 2024 | 0.98 | -0.05 | -4.85% | 1.03 | 1.03 | 0.93 |
| Apr 1, 2024 | 1.00 | -0.02 | -1.96% | 1.02 | 1.03 | 0.98 |
| Mar 28, 2024 | 0.99 | -0.02 | -1.98% | 1.01 | 1.02 | 0.96 |
| Mar 27, 2024 | 0.97 | 0.04 | 4.30% | 0.93 | 0.99 | 0.92 |
| Mar 26, 2024 | 0.90 | 0.01 | 1.12% | 0.89 | 0.93 | 0.89 |
| Mar 25, 2024 | 0.89 | -0.17 | -16.04% | 1.06 | 1.06 | 0.89 |
| Mar 22, 2024 | 1.04 | -0.03 | -2.80% | 1.07 | 1.10 | 1.03 |
| Mar 21, 2024 | 1.09 | 0.01 | 0.93% | 1.08 | 1.26 | 1.07 |
| Mar 20, 2024 | 1.10 | 0.08 | 7.84% | 1.02 | 1.12 | 0.99 |
| Mar 19, 2024 | 1.01 | 0.01 | 1.00% | 1.00 | 1.07 | 0.97 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Mustang Bio, Inc. Company profile
About Mustang Bio Inc
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is focused on three core areas: gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Its products include MB-107 and MB-207 is Ex vivo Lentiviral Therapy for X-linked Severe Combined Immunodeficiency (XSCID). XSCID is a rare genetic immune system condition also known as bubble boy disease. Its MB-102 is a CD123 CAR T cell Program for blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Financial summary
BRIEF: For the nine months ended 30 September 2021, Mustang Bio Inc revenues was not reported. Net loss increased 18% to $46.3M. Higher net loss reflects Research and development - Balan increase of 35% to $33.4M (expense), General and administrative - Balancin increase of 28% to $7.5M (expense), Stock-based Compensation in R&D increase of 41% to $1.6M (expense).
| Industry: | Bio Therapeutic Drugs |
377 Plantation Street
01605
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com